Top Industry Leaders in the Diphtheria Treatment Market
Latest Diphtheria treatment Companies Updates:
Jan 2024
Serum Institute of India Expanded their production capacity of Diphtheria Antitoxin (DAT) to meet the rising demand, particularly in low- and middle-income countries.Collaborated with WHO and UNICEF to improve DAT supply chain management and ensure timely access to treatment in outbreak situations.
Walvax Biotechnology Received Chinese regulatory approval for their recombinant DAT product, offering an alternative to traditional horse-derived antitoxin with potential for reduced side effects.Focused on research and development of next-generation DAT formulations with longer shelf life and improved stability.
Bharat Biotech International Received funding from the Bill & Melinda Gates Foundation to develop a combination vaccine against diphtheria, tetanus, and pertussis, potentially improving vaccination coverage and reducing disease burden.Partnered with academic institutions to explore alternative sources for DAT production, such as genetically modified plants, for sustainable and affordable supply.
Bavarian Nordic A/S Developed a multi-component vaccine containing diphtheria toxoid, offering protection against multiple diphtheria-related toxins and strains.Conducted research on novel vaccine delivery platforms like microneedles for potentially painless and improved diphtheria immunization.
Statens Serum Institute Launched an educational campaign promoting awareness of diphtheria symptoms and the importance of timely vaccination.Collaborated with healthcare professionals to improve diphtheria diagnosis and treatment protocols.
List of Diphtheria Treatment Key companies in the market
- Taj Pharmaceuticals Limited,
- Bharat Pharmaceuticals,
- GSK, Sanofi-Pasteur,
- Merck & Co.,
- Shanghai Institute of Biological Products,
- Wuhan Institute of Biological Products,
- Serum Institute of India,
- Wyeth,
- Chiron Pharmaceutical Pvt Ltd.
